Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers

Archive ouverte

Alsafadi, Samar | Dayot, Stephane | Tarin, Malcy | Houy, Alexandre | Bellanger, Dorine | Cornella, Michele | Wassef, Michel, M. | Waterfall, Joshua, J | Lehnert, Erik | Roman-Roman, Sergio | Stern, Marc-Henri | Popova, Tatiana

Edité par CCSD ; Nature Publishing Group [1987-....] -

International audience. Genes involved in 3′-splice site recognition during mRNA splicing constitute an emerging class of oncogenes. SF3B1 is the most frequently mutated splicing factor in cancer, and SF3B1 mutants corrupt branchpoint recognition leading to usage of cryptic 3′-splice sites and subsequent aberrant junctions. For a comprehensive determination of alterations leading to this splicing pattern, we performed a pan-TCGA screening for SF3B1-specific aberrant acceptor usage. While the most of aberrant 3′-splice patterns were explained by SF3B1 mutations, we also detected nine SF3B1 wild-type tumors (including five lung adenocarcinomas). Genomic profile analysis of these tumors identified somatic mutations combined with loss-of-heterozygosity in the splicing factor SUGP1 in five of these cases. Modeling of SUGP1 loss and mutations in cell lines showed that both alterations induced mutant-SF3B1-like aberrant splicing. Our study provides definitive evidence that genetic alterations of SUGP1 genocopy SF3B1 mutations in lung adenocarcinoma and other cancers.

Suggestions

Du même auteur

Splicing Patterns in SF3B1 -Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific Neoepitopes

Archive ouverte | Bigot, Jeremy | CCSD

International audience. Abstract Disruption of splicing patterns due to mutations of genes coding splicing factors in tumors represents a potential source of tumor neoantigens, which would be both public (shared bet...

A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome

Archive ouverte | Bondu, Sabrina | CCSD

International audience. Myelodysplastic syndromes (MDS) with ring sideroblasts are hematopoietic stem cell disorders with erythroid dysplasia and mutations in the SF3B1 splicing factor gene. Patients with MDS with S...

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma

Archive ouverte | Decaudin, Didier | CCSD

International audience

Chargement des enrichissements...